Ciprofloxacin pharmacokinetics in burn patients.

Many drugs exhibit altered pharmacokinetic parameters in burn patients. We prospectively evaluated the pharmacokinetics of ciprofloxacin in eight burn patients with active infections. Each patient received a 400-mg dose of ciprofloxacin intravenously (i.v.) every 8 h, with each dose infused over 1 h...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Garrelts, J C, Jost, G, Kowalsky, S F, Krol, G J, Lettieri, J T
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1996
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163282/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8723457/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.5.1153
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!